2026 Winter Cancer Symposium | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

2026 Winter Cancer Symposium | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

Overview

NA

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Jane Lowe Meisel, MD, FASCO

Date of Release

March 9th, 2026